Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score N/A
- Piotroski Score N/A
- Grade Neutral
- Symbol (TRIT)
- Company Triterras, Inc.
- Price $1.64
- Changes Percentage (0%)
- Change -$0
- Day Low $1.64
- Day High $1.85
- Year High $1.85
Triterras, Inc. operates as a fintech company. It operates Kratos, a commodity trading and trade finance platforms that connects and enables commodity traders to trade and source capital from lenders directly online. The company is headquartered in Singapore.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 12/03/2020
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating N/A
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.00
- Trailing P/E Ratio N/A
- Forward P/E Ratio N/A
- P/E Growth N/A
- Net Income $0
Income Statement
Quarterly
Annual
Latest News of TRIT
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Dave Coulier Details How Wife Melissa Has Created a 'Whole Nutrition Plan' for Him amid His Cancer Journey (Exclusive)
Dave Coulier, known from Full House, shared his battle with stage 3 non-Hodgkin lymphoma. His wife, Melissa, supports him with a nutrition plan from her wellness company and removing sugar from his di...
By PEOPLE.com | 6 days ago -
These foods can help you focus, nutritionists say
Eating the right foods can significantly impact focus and brain health. Nutritional therapists recommend foods like oily fish, nuts, seeds, berries, leafy greens, and avoiding sugary snacks, refined c...
By Newsweek | 1 week ago -
Triton Weighs Takeover Deal for Drug Developer Evotec
Private equity firm Triton Partners is considering a takeover bid for Evotec SE after acquiring a 9.99% stake. The move requires approval to increase holdings, potentially involving major shareholders...
By Yahoo! Finance | 1 week ago
